Introduction of the multilink stent into routine angioplasty practice: Early angiographic and clinical outcome

Ruygrok, Peter; Barron, Garry; Ormiston, John A.; Meredith, Ian T.; Webster, Mark; Harper, Richard W.; Saltups, A.; O’Shaughnessy, Ben; Stewart, James T.

doi:10.1002/(sici)1097-0304(199802)43:2<147::aid-ccd8>3.0.co;2-a

Cited by 3 publications

(2 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite this, there were very few adverse clinical events. These findings compare favorably with those of randomized trials of stent implantation in highly selected patient and lesion groups and registry data [2][3][4][5][6][7][8][9][10][11]. The use of stents during coronary interventional procedures has increased dramatically over the 6 years since the Benestent and STRESS trials demonstrated reduced restenosis rates with stent deployment compared with angioplasty for focal de novo coronary artery lesions [2,3].…”

Section: Discussionsupporting

confidence: 53%

“…This has been particularly apparent over the last 6 years, exemplified by our unit where stents were used in only 13% of procedures in 1992 compared to over 80% in 1998. A major reason for their increased usage is the availability of newer designs that have overcome the limitations of earlier generation stents [5][6][7][8][9][10][11]. This article describes our initial clinical experience obtained in a consecutive series of patients with a full spectrum of coronary lesions undergoing V-Flex Plus stent deployment.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Preliminary experience with the V-Flex Plus coronary stent: Immediate and one-month clinical outcome

Rhydwen

Webster

Ruygrok

et al. 1999

Cathet. Cardiovasc. Intervent.

Self Cite

View full text Add to dashboard Cite

Procedural and 1‐month outcome data following implantation of the V‐Flex Plus stent in our first 54 consecutive patients (35 male; mean age, 62 years) are described. Sixty‐four stents were implanted for 60 mainly complex lesions; 48% were left anterior descending; 20%, circumflex; 27%, right coronary artery; and 5%, saphenous vein graft. The indication for stenting was elective in half of the patients and for a suboptimal result or as a bailout procedure in the other half. The stents were deployed at a mean of 12 atm (range, 6–18) and postdilated to a mean of 15 atm (range, 8–20). Pre‐ and postdilatation balloon sizes were 2.96 ± 0.57 mm and 3.16 ± 0.34 mm, respectively. The procedural success rate was 98%. There were no deaths or Q‐wave myocardial infarctions. One patient suffered a non–Q‐wave myocardial infarction and another developed a femoral false aneurysm. At 1‐month follow‐up, there were no additional events, in particular no revascularization procedures. Eighty‐nine percent of patients were free of angina. Implantation of the V‐Flex Plus stent is safe and effective with an excellent early success rate comparable to that of published randomized trials and registries of carefully selected patients. Cathet. Cardiovasc. Intervent. 47:504–508, 1999. © 1999 Wiley‐Liss, Inc.

show abstract

Section: Discussionsupporting

confidence: 53%

Section: Introductionmentioning

confidence: 99%

Preliminary experience with the V-Flex Plus coronary stent: Immediate and one-month clinical outcome

Rhydwen

Webster

Ruygrok

et al. 1999

Cathet. Cardiovasc. Intervent.

Self Cite

View full text Add to dashboard Cite

show abstract

Acute and long‐term clinical and angiographic outcome after S‐Stent implantation: S‐Stent multicenter safety and efficacy trial

Chan

Lim

Santoso

et al. 2004

Cathet Cardio Intervent

View full text Add to dashboard Cite

The purpose of this study is to demonstrate safety and effectiveness of the S-Stent in de novo coronary lesions treated with conventional percutaneous coronary balloon angioplasty. Between January 2000 and June 2001, 120 patients were prospectively enrolled at four study centers. Patients were treated with coronary stenting in a total of 137 lesions. Procedural success was achieved in 100% of 137 attempted lesions. Clinical success was 99.8%. In-hospital mortality was 0.8%; myocardial infarction occurred in 0.8% and stent thrombosis in 0.8%. After stent implantation, the minimal lumen diameter increased from 0.92 +/- 0.43 to 2.74 +/- 0.36 mm (P < 0.0001) and the percent diameter stenosis decreased from 68.0 +/- 16.2 to 4.5 +/- 12.0 (P < 0.0001). At 6-month follow-up, the percent diameter stenosis was 33.5 +/- 21.3 and the angiographic restenosis rate was 16.5%. Target lesion revascularization was required in 12 patients (10.1%). We conclude that the use of S-Stent for coronary intervention resulted in a high procedural success rate and low angiographic restenosis at 6 months after implantation.

show abstract

Clinical and angiographic results of coronary artery stenting using PURA-VARIO (PUVA) stents

Germing

Lindstaedt

Machraoui

et al. 2003

International Journal of Cardiovascular Interventions

View full text Add to dashboard Cite

show abstract

Introduction of the multilink stent into routine angioplasty practice: Early angiographic and clinical outcome

Cited by 3 publications

References 13 publications

Preliminary experience with the V-Flex Plus coronary stent: Immediate and one-month clinical outcome

Preliminary experience with the V-Flex Plus coronary stent: Immediate and one-month clinical outcome

Acute and long‐term clinical and angiographic outcome after S‐Stent implantation: S‐Stent multicenter safety and efficacy trial

Clinical and angiographic results of coronary artery stenting using PURA-VARIO (PUVA) stents

Contact Info

Product

Resources

About